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1. Introduction   
Gastroparesis, a gastric motility disorder characterized by delayed gastric emptying without 
evidence of mechanical obstruction (Nilsson, 1996), clinically presents as nausea, vomiting, 
abdominal pain, with a compromised nutritional state. Gastroparesis has multiple etiologies 
but the dominant ones are diabetes (DM), idiopathic (ID) and post-surgical (P-S). Frequent 
hospital admissions, and severe symptoms make gastroparesis patients socially restricted 
(Soykan et al., 1998). Approximately one third of gastroparesis cases are caused by diabetes 
mellitus. Diabetic gastroparesis may be attributed to impaired motor activity involving 
gastric hypomotility and unpropagated contractions (lack of peristalsis) and/or impaired 
myoelectrical activity explained by abnormal frequency of the gastric slow wave 
(dysrhythmia), low amplitude and/or uncoupling of slow waves (You et al., 1980; Telander 
et al.,1978; Geldof et al.,1986; Chen et al., 1992). 
The most common treatment for gastroparesis is the use of prokinetic agents, such as 
metoclopramide, erythromycin and domperidone. However, only two agents are currently 
available in the USA, metoclopramide and erythromycin. Side effects from these agents 
result in up to 40% of patients being unable to tolerate chronic use (Sturm et al., 1999). Those 
who are refractory or intolerant to prokinetic agents often undergo abdominal surgery for 
the placement of a feeding jejunostomy tube which is only for nutritional support and does 
not improve gastric motility (Reardon et al., 1989; Ejskjaer et al., 1999). 
Gastric electrical stimulation (GES) is an emerging therapy for refractory gastroparesis. 
Currently two types of GES have been investigated for treatment of gastroparesis: (i) long-
pulse or high energy with low frequency stimulation and (ii) short-pulse or low energy with 
high frequency stimulation.  Gastric electrical stimulation (GES) with short pulses and low 
energy (Enterra Device) was FDA approved in 2000 as a therapeutic option in the 
management of refractory gastroparesis (Familoni et al., 1997; Forster et al., 2001; Abell et 
al., 2002, 2003). Long-pulse and high energy stimulation, another approach to GES, achieves 
gastric pacing and represents a promising new treatment for gastric motility disorders 
(Hocking et al., 1992; McCallum et al., 1998; Lin et al., 1998). In this method, the electrical 
stimulus is composed of repetitive single pulses with a pulse width in the order of 
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milliseconds (10-600 ms), and a stimulation frequency in the vicinity of the physiological 
frequency of the gastric slow wave. Single-channel GES with a pair of electrodes located in the 
mid-body of the stomach and using long pulses is able to normalize gastric dysryhthmia 
(Hocking et al., 1992; McCallum et al., 1998; Lin et al., 1998; Qian et al., 1999) and improve 
gastric emptying in both patients with gastroparesis and animal models of gastroparesis 
(McCallum et al., 1998; Bellahsene et al., 1992). Recently, two or four-channel GES with long 
pulses has been investigated and the preliminary results from several studies in both healthy 
and diseased canine models are promising (Song et al., 2005; Chen et al., 2005; Xu et al., 2008). 
Compared with single-channel GES, multi-channel GES is substantially more effective in 
entraining gastric slow waves and accelerating gastric emptying. However, the mechanisms 
underlying symptomatic improvement by GES remain unclear. Animal studies have shown 
that GES with high frequency and low energy parameters affects autonomic function. The 
aims of this chapter were to evaluate the effect of GES on autonomic function in patients with 
gastroparesis and identify possible mechanisms that could help explain how GES is effective in 
treating nausea and vomiting associated with refractory gastroparesis.  
2. Methods  
2.1 Subjects  
Twenty nine gastroparetic patients were enrolled in two studies. Study I was performed in 
10 gastroparetic patients (2 men and 8 women; mean age, 44 years; range, 20-58 years) with 
severe gastroparesis (7 diabetic, 3 idiopathic) refractory to standard medical therapies 
treated with short-pulse GES using an implantable neurostimulator (ENTERRATM Therapy 
System, Medtronic, Minneapolis, MN). Nineteen diabetic gastroparetic patients (8M, 11F, 
mean age: 41 years, range: 26-60) refractory to standard medical therapy were included in 
Study II and they were treated with long-pulse GES using an external multi-channel pulse 
stimulator (GI Stimulation Inc., Charlottesville, VA).  
The entry criteria included 1) delayed gastric emptying of a solid meal (>60% gastric retention 
at 2 hours and >10% at four hours after eating) using a standardized 4-hour scintigraphic 
method (Tougas et al., 2000); 2) more than 7 episodes of vomiting and/or nausea per week; 3) 
symptoms of gastroparesis for longer than one year; 4) refractoriness or intolerance to 2 of 3 
classes of prokinetic drugs (cholinergic agonists, motilin receptor agonists, and dopamine 
receptor antagonists) and 2 of 3 classes of antimetics (anticholinergics/antihistamines, 
serotonin receptor antagonists, and dopamine receptor antagonists). Patients with 
documented organic or intestinal pseudo-obstruction, primary eating or swallowing disorders, 
chemical dependency, a diagnosis of active malignancy, positive pregnancy test or 
psychogenic vomiting were excluded. The study protocol was approved by the Human 
Subjects Committee at University of Kansas Medical Center, Kansas City, Kansas and written 
consent forms were obtained from all subjects before the study. 
2.2 Study design  
Each study consisted of a baseline, within two weeks before surgery for implantation of GES 
system, and follow-up sessions 6 weeks after GES therapy was initiated. In each session, a 
total symptom score (TSS) derived from 7 upper GI symptom sub-scores using a 5-point 
scale was assessed and electrocardiogram (ECG) were measured for 30 min in the fasting 
state and for 60 min after a caloric liquid meal (240 kcal). Autonomic activity was assessed 
by spectral analysis of the heart rate variability.  
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2.3 Surgical and GES techniques  
The GES system for Enterra therapy used in study I consisted of 3 components: a battery-
powered implantable pulse generator (Medtronic Model 3116, Medtronic), 2 intramuscular 
electrodes (Model 4300, Medtronic) (Figure 1) and an external programmer (Medtronic 
N’Vision clinician programmer 8840) to adjust the output parameters of the pulse generator. 
One pair of permanent electrodes (about 1 cm apart) was inserted during laparotomy into 
the muscularis propria layer on the greater curvature at 9.5 and 10.5 cm proximal to the 
pylorus. The electrodes were secured to the serosa of the stomach using 5-0 silk sutures and 
plastic disks.  The other end of each electrode was connected to the pulse generator which 
was positioned in a subcutaneous pocket in the abdominal wall to the right of the umbilicus. 
The load impedance of the circuit was checked both before and after the GES device was 
placed in the pocket using the external programmer. The pulse generator was usually 
activated in the operating room or within 48 hours after surgery and initially programmed 
to standardized parameters: pulse width, 330 s; (current) amplitude, 5 mA; frequency, 14 
Hz; cycle ON: 0.1 seconds; cycle OFF, 5.0 seconds.  At various intervals of follow-up after 
the implant, those parameters can be adjusted based on patient’s symptomatic status or 
changes in impedance reading.  
 
Location of Gastric Electrodes
For recording
For stimulation
11-12 cm for recording
1
2
34
7-8 cm for stimulation
 
Fig. 1. The location of permanent electrodes for implantable Enterra device and temporary 
electrodes for external stimulation by a multi-channel gastric pulse generator (MGP). During 
laparotomy to place a permanent gastric neurostimulator, a pair of intramuscular electrodes 
were implanted into the gastric muscle at 9 and 10 cm from the pylorus on the greater 
curvature of the stomach and connected to the Enterra device. Then 4 pairs of serosal 
electrodes for gastric pacing were sewed on the serosa of the greater curvature of the 
stomach. The electrodes utilized for stimulation where at 15-16 and 7-8 cm from the pylorus 
whereas the electrodes for recordings the signal were located at 11-12 and 3-4 cm from the 
pylorus.  
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After laparotomy for implantation of permanent electrodes and pulse generator for the 
Enterra Therapy, four pairs of bipolar temporary electrodes used for gastric pacing in Study 
II were sewed on the serosa of the greater curvature of the stomach with an inter-electrode 
distance of 1 cm using a previously published method (McCallum et al., 1998; Lin et al., 
1998). These four pairs of electrodes were TPW62 multifilament surgical steel temporary 
cardiac pacing wires (Ethicon, Inc, Somerville, NJ, USA). The most distal pair of electrodes 
was positioned 3-4 cm above the pylorus and the most proximal one, 15-16 cm above. The 
interval between two pairs of electrodes was 4 cm (Figure 1). The first pair (the most 
proximal pair) and the third pair of electrodes at 7 to 8 cm proximal to the pylorus were for 
electrical stimulation. The second and the fourth pairs at 11 to 12 cm and at 3 to 4 cm 
proximal to the pylorus respectively were for recording of gastric electrical activity. Wires 
from the electrodes were brought out through the abdominal wall percutaneously and 
placed under a sterile dressing to be connected to an external pulse generator for the study. 
Four to five days after surgery the function of the electrodes was validated by 4 channel-
serosal recordings and the optimal pacing parameters for entrainment of gastric slow waves 
in each patient were identified using a newly developed external multi-channel pulse 
generator (GI Stimulation Inc., Charlottesville, VA) (see Figure 1).  Before being sent home 
with a portable multi-channel pulse generator, the patient was trained on how to connect 
the electrodes to the external pulse generator, activate and care for the device. The patients 
were asked to place the device in a fanny pack for protection during the day and to self-
administer GES 30 minutes before each meal, during the meal and 4 hours after each meal 
and to disconnect the pulse generator from the electrodes and charge the battery at night. 
The parameters utilized were determined by optimization session outlined above: two-
channel pacing at 1.1 times the intrinsic frequency ranging from 3 to 3.5 cpm, a pulse width 
of 10 to 300 ms and the amplitude of 0.5 to 3 mA. The phase shift of electrical stimuli 
between the first and third stimulation channels was adjusted to be the same as the intrinsic 
phase shift calculated from the baseline slow wave recording and varied from 8 to 10 
seconds. Enterra device was turned OFF and kept inactivated for the duration of the study 
II.  
2.4 Recording and analysis of Heart Rate Variability (HRV)  
After the patient fasted for at least 12 hours, one-channel ECG was measured for at least 30 
minutes using the UFI Bio-Amplifier (UFI, Morro Bay, CA). Prior to the attachment of 
electrodes (BioTac, Graphic Controls Corporation, Buffalo, NY), the chest where the electrodes 
were to be positioned was shaved if applicable (in males) and cleaned with sandy skin-prep 
paste to reduce the impedance. Three electrodes were placed on the chest for recording ECG. 
To avoid motion artifact, the patients were asked to lie quietly in supine position on the bed 
and try to be as still as possible during the recording period. Analysis of autonomic function 
was accomplished through power spectral analysis of heart rate variability (HRV) (Figure 2). 
The following parameters were computed from the ECG recordings using a validated 
program (Wang & Chen, 2000; Oppenheim, A.V. & Schafer, 1975): (a) average and standard 
deviation of the heart rate, (b) spectral components of HRV in low frequency band (PL: 0.04 – 
0.15 Hz) and in high frequency band (PH: 0.15 – 0.4 Hz), (c) the percentage of power in low 
frequency band, P1= (PL/(PL+PH) %) and the percentage of power in high frequency band, 
P2= (PH/(PL+PH) %) and (d) PL/PH, which measures sympathovagal balance, with higher 
values indicating greater overall sympathetic dominance.  
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2.5 Assessment of upper GI symptoms 
Each patient completed a self assessment Symptom Interview Form at baseline and after 6 
weeks of active GES. This form assessed the symptoms of gastroparesis occurring during the 
2 weeks before the interview and the two last weeks of a total  6 weeks of GES  therapy for 
severity of vomiting, nausea, early satiety, bloating, postprandial fullness, epigastric pain, 
and epigastric burning. The severity of each symptom was graded by the patients as 0 = 
absent, 1 = mild (not influencing the usual activities), 2= moderate (diverting from, but not 
urging modifications, of usual activities), 3 = severe (influencing usual activities, severely 
enough to urge modifications) and 4 = extremely severe (requiring bed-rest). The sum of the 
severity ratings of the 7 symptom sub-scores comprised the overall total symptom score 
(TSS) for severity.   
 
 
(a) 
 
(b) 
Fig. 2. Examples of (a) electrocardiogram recording, (b) time-domain signal of heart rate 
variability (HRV) (upper panel) and spectral analysis of heart rate variability signal (lower 
panel). PL: power in low frequency band; PH: power in high frequency band; PVL: power in 
very-low frequency band; PTOTAL: total power. 
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2.6 Statistical analysis 
All data are expressed as mean ± SD. Analysis of variance (ANOVA) and paired t-test were 
used to determine significant difference between baseline and follow-up visit (Microsoft 
Excel, Redmond, WA). Statistical significance was assigned for P<0.05.  
3. Results  
Similar results were observed in these two studies.  
In study I, the results of heart rate (HR), power in the low frequency band (0.04-0.15 Hz), 
power in the high frequency band (0.15-0.4 Hz) and power ratio (PL/PH) are summarized in 
Table 1. Figure 3 shows (a) individual percentages of power in the low-frequency band and 
(b) in high-frequency band derived from heart rate variability before and after Enterra GES.  
The sympathovagal balance (PL/PH) was significantly decreased after Enterra GES therapy 
with low energy and high frequency parameters (2.2±0.6 vs. 0.5±0.2), indicating a significant 
increase in vagal activity during Enterra GES. Severity of nausea and vomiting and TSS was 
significantly reduces after GES therapy (see table 2). The mean symptom reduction in TSS 
was substantially greater in 7 patients who had a decrease in the sympathovagal balance 
than that in 3 patients who had an increase in the sympathovagal balance (59% vs. 26%).  
 
 Mean HR (beats/min) SD P1 (%) P2 (%) PL/PH 
Before GES 98.7 60.1 69 31 2.2 
During GES 88.2 40.0 34 66 0.5 
P values (t-test) NS NS NS 0.04 0.04 
Table 1. Comparison of heart rate variability (HRV) before and during gastric electrical 
stimulation (GES). Note: HR, heart rate; SD, standard deviation; P1, the percentage of power 
in low frequency band; P2, the percentage of power in high frequency band; PL, power in 
high frequency band; PH, power in high frequency band. NS, not significant. 
 
 
                                            (a)                                                                     (b) 
Fig. 3. (a) Individual percentages of power in the low-frequency band and (b) in high-
frequency band derived from heart rate variability before and during gastric electrical 
stimulation (GES) (Mean data also included for comparison). 
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 Before GES During  GES P value (t-test) 
Nausea score (0-4) 3.80.1 1.70.4 <0.05 
Vomiting score (0-4) 2.20.4 1.80.5 <0.05 
TSS  in severity (0-28) 23.10.8 11.5±2.6 <0.01 
Table 2. Results of gastroparetic symptom responses in Study I. Note: TSS (Total Symptom 
Score) derived from 7 upper GI symptom sub-scores (vomiting, nausea, early satiety, 
bloating, postprandial fullness, epigastric pain and burning) using a 5-point scale (0=none, 
4=extremely severe) before and after initiation of GES (Gastric Electrical Stimulation). 
In study II, the PL/PH was significantly decreased from 0.45±0.05 at baseline to 0.28±0.04 after 6 
weeks of two-channel GES with high energy and low-frequency parameters. Figure 4 shows 
the effect of the two-channel gastric pacing on the spectral components of HRV. Severity for 
each GP symptom (nausea, vomiting, early satiety, bloating, postprandial fullness, epigastric 
pain, and epigastric burning) was significantly reduced after 6 weeks of two-channel gastric 
pacing (P<0.01, Figure 5). Therefore, the significant reduction of TSS from 21.3±1.1 at baseline 
to 7.0±1.5 after 6 weeks of two-channel gastric pacing was observed. 
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Fig. 4. Effect of two-channel gastric pacing on the spectral components of the HRV. 
Comparing to baseline, the high frequency component of the HRV increased significantly 
during two-channel gastric pacing. P1, the percentage of power in low frequency band; P2, 
the percentage of power in high frequency band. 
4. Discussion and conclusion  
This study identifies significantly enhanced vagal activity during chronic GES with both 
Enterra therapy and two-channel gastric pacing while significantly improving upper GI 
symptoms. These observations augment previous reports on the purported mechanisms of 
high-frequency GES therapy (Tougas & Huizinga, 1998; Tack et al., 1999; Al-Jubiri et al., 2001; 
Wang et al., 2001; Liu et al., 2004; Luo et al., 2005; Lin et al., 2004, 2008; McCallum et al., 2010). 
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Fig. 5. Comparison of individual upper gastrointestinal symptoms (vomiting, nausea, early 
satiety, bloating, postprandial fullness, epigastric pain and epigastric burning) using a 
severity grading scale of 0 to 4 with a maximum of 28 points between baseline and after 6 
weeks of Multi-channel Pulse Generator (MPG) gastric pacing. There was a significant 
reduction in all symptoms (P<0.01) after 6 weeks of GES. 
The most common symptoms of gastroparesis patients are vomiting and nausea. In our 
study, we proved that GES with both Enterra device and two-channel gastric pacing 
significantly reduced voniting and nausea of gastroparesis patients. This would be a reliable 
evidence to demonstrate significant benefits for GES in the treatment of refractory 
gastroparesis. A certain number of studies investigated the mechanism of high-frequency 
GES to improve symptoms of gastroparesis, which included adrenergic and cholinergic 
functions  (Luo et al., 2005), fundic relaxation  (Tack et al., 1999), GI hormones  (Al-Jubiri et 
al., 2001) and afferent brain stem pathways  (Tougas & Huizinga, 1998), improvement of 
gastric emptying (Lin et al., 2008), activation of vagal afferent pathways to influence CNS 
control mechanisms for nausea and vomiting, and decreasing gastric sensitivity to volume 
distention which enhanced postprandial gastric accommodation  (McCallum et al., 2010). 
The autonomic nervous system (ANS) is involved in the modulation of normal 
gastrointestinal function. It consists of extrinsic control exerted by the parasympathetic and 
sympathetic nervous system (Thumshirn & Camilleri, 2004). A number of methods have 
been developed to assess specific aspects of autonomic nervous function. In recent years the 
development of techniques based on the autonomic modulation of heart rate function have 
largely replaced other methods because of their simplicity and validity as markers of vagal 
as well as sympathetic function (Tougas et al., 1997; Tougas, 2000). The power spectral 
analysis of the heart rate variability (HRV) derived from the electrocardiogram now 
provides a simple and accurate measure of the respective outflow of the vagal and 
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sympathetic branches of the ANS (Kamath & Fallen, 1993). Preliminary studies in animals 
using spectral analysis of HRV have shown that short-pulse GES significantly increased 
vagal activity at a frequency four times the intrinsic slow-wave frequency and is mediated 
via the vagal efferent pathway (Liu et al., 2004; Wang et al., 2001). These short-pulse and 
high-frequency stimulation parameters have been used in previous clinical trials (Familoni 
et al., 1997; Forster et al., 2001; Abell et al., 2002, 2003) and in clinical practice. In this current 
study, we used power spectral analysis of heart rate variability derived from raw ECG 
recordings to assess the effect of GES on autonomic function and found that the 
sympathovagal balance (power in the low frequency band/power in high frequency band) 
was significantly decreased during GES therapy with both Enterra therapy and two-channel 
gastric pacing, attributing to an increase in vagal activity. To our knowledge, this is the first 
study to demonstrate that these stimulation parameters would evoke a similar change in 
vagal activity in humans as previously observed in the dog (Liu et al., 2004; Wang et al., 
2001). 
In conclusion, GES with Enterra therapy and two-channel gastric pacing in patients with 
severe gastroparesis results in a decrease in the sympathovagal balance (power in the low 
frequency band/power in high frequency band), indicating a significant increase in vagal 
activity while significantly improving upper GI symptoms. These findings are one 
explanation for the significant symptomatic improvement induced by GES in these patients 
with refractory gastroparesis.  
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